Home > Income Statement > BAL PHARMA

BAL PHARMA
Revenue

    Back to Income Statement
BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹303 Cr₹339 Cr₹304 Cr₹281 Cr₹251 Cr

What is the latest Revenue of BAL PHARMA ?

The latest Revenue ratio of BAL PHARMA is ₹303 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹303 Cr
Mar2025₹339 Cr
Mar2024₹304 Cr
Mar2023₹281 Cr
Mar2022₹251 Cr

How is Revenue of BAL PHARMA Trending?

Years Revenue % Change
Mar2026 ₹303 Cr
-10.65
Mar2025 ₹339 Cr
11.51
Mar2024 ₹304 Cr
8.18
Mar2023 ₹281 Cr
12.25
Mar2022 ₹251 Cr -

Compare Revenue of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹171.6 Cr 5.8% 26.4% 24.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,476.0 Cr -0.1% -2.4% 13.8% Stock Analytics
DIVIS LABORATORIES ₹254,764.0 Cr 2.7% 12.9% 54.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,423.0 Cr 1.8% 2.5% 40.9% Stock Analytics
CIPLA ₹111,484.0 Cr 0.6% -3.8% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,005.0 Cr 3.3% 1.3% -7.6% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

5.8%

26.4%

24.3%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses